EUVIMEDEUVIMED entdecken
Crossref

Discovery and Mechanistic Characterization of Tetrahydroisoquinoline Derivatives as Inhibitors of SARS‐CoV‐2 Main Protease

Wenhui Zhang, Nuoya Wang, Wenquan Yu, Yahong Chen, Xiaoyu Chang, Ruiyong Wang

Israel Journal of Chemistry · 2026-11 · 66 (6)

DOI: 10.1002/ijch.70052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Israel Journal of Chemistry, online erschienen am 05.11.2026. Verfasst von Wenhui Zhang und 5 weiteren Autor:innen. Die Arbeit nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS‐CoV‐2 main protease (Mpro) is an enzyme for viral replication and an target for antiviral drugs due to its evolutionary conservation across coronaviruses and the absence of closely related human homologs. Tetrahydroisoquinoline (THIQ) derivatives represent a structurally diverse class of nitrogen‐containing heterocycles with proven versatility in medicinal chemistry. Thirty newly synthesized compounds, including THIQ‐based molecules and structurally related amine analogs, were evaluated for their inhibitory activity against Mpro. Six compounds exhibited significant inhibitory potency (IC 50 < 50 μM). Compound 3ia, containing nitro and para ‐bromophenyl groups, was the most active candidate with an IC 50 of 6.61 μM. Fluorescence quenching and thermodynamic analyses revealed that the interactions between active compounds and Mpro occurred predominantly via static quenching. Results demonstrated that compound binding induced conformational changes in Mpro. Differential scanning fluorimetry (DSF) showed that all active compounds increased the thermal stability of Mpro, and microscale thermophoresis (MST) confirmed high‐affinity binding ( K d = 25.92 μM for 3ia ). Molecular docking further revealed that the THIQ scaffold of 3ia inserts into the Mpro substrate‐binding pocket, forming π–sulfur interactions with the catalytic Cys145. This work confirms THIQ as a promising lead scaffold for Mpro inhibitors and supports the structure‐based design of improved anticoronavirus candidates.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, W., Wang, N., Yu, W., Chen, Y., Chang, X., & Wang, R. (2026). Discovery and Mechanistic Characterization of Tetrahydroisoquinoline Derivatives as Inhibitors of SARS‐CoV‐2 Main Protease. Israel Journal of Chemistry, 66(6). https://doi.org/10.1002/ijch.70052

Vancouver

Zhang W, Wang N, Yu W, Chen Y, Chang X, Wang R. Discovery and Mechanistic Characterization of Tetrahydroisoquinoline Derivatives as Inhibitors of SARS‐CoV‐2 Main Protease. Israel Journal of Chemistry. 2026;66(6). doi:10.1002/ijch.70052

BibTeX
@article{Zhang2026,
  author = {Zhang, Wenhui and Wang, Nuoya and Yu, Wenquan and Chen, Yahong and Chang, Xiaoyu and Wang, Ruiyong},
  title = {Discovery and Mechanistic Characterization of Tetrahydroisoquinoline Derivatives as Inhibitors of SARS‐CoV‐2 Main Protease},
  journal = {Israel Journal of Chemistry},
  year = {2026},
  volume = {66},
  number = {6},
  doi = {10.1002/ijch.70052}
}
Kostenlos starten →